Introduction
The required uniform assignment for this group is the clinical manifestation in Analysis of Risks for Advanced Maternal Age, which refers to the natural biological symptoms where the person giving birth is past 35 years. It is commonly witnessed in women living in their late 30s, although the average age of geriatric pregnancy in the United States is said to stand at 35 years. Geriatric pregnancy is a natural occurrence in human biology, and individuals in this group are at more risk for complications such as high blood pressure and miscarriage. The team aims to analyze the negative impact that maternal age has on the individual and the family. Early physical symptoms of menopause, such as congenital disorders and emotional symptoms, may interfere with one’s sleep and affect their general emotional health.
Regarding patient outcomes, the limited understanding contributes to delayed recognition of the transition and taking part in system management. The active group of women in this research exercise suggests a more uniform take toward maternal age readiness, including patient and clinician education. In addition, it provides legislative solutions to overcome regulatory barriers to treatment to better the care and quality of life throughout the maternal age transition. Statistically, the post-menstrual life of an average woman constitutes about 40% of her life due to an increase in life expectancy (Takahashi et al., 2017). If the conditions are not observed in advance, then the transition is likely to cause a problem in the quality of life and possibly even the life expectancy.
The PICOT question for this group is: Should maternal age be regarded as a normal part of aging after 35 years, or is it the cause of health deterioration as far as women’s health is concerned? This paper aims to evaluate the research strategies used in two articles that address the maternal age issue in the PICOT question.
Levels of Evidence
The PICOT question resembles a prognosis question since the individuals are investigated to deduce whether their health after the maternal age remains constant or deteriorates. The question analyzes the health progress of the participants from disease resistance to age-related diseases.
A Randomized Control Test (RCT) is the most appropriate evidence to apply in this research to avoid biases. The participants will be chosen randomly from an eligible population, and a control group will be picked randomly from the same population. This type of evidence is often underused in nursing research compared to other research methods. The method can offer the needed answers to the clinical PICOT questions when adequately powered and well conducted.
The RCT has significant merits in that when appropriately applied, it eliminates any population bias around ethnicity or gender. It makes it easy to obtain valid results compared to other observational studies. Another significant strength is that statistical tools can analyze it. The presence of a control experiment helps in drawing meaningful conclusions. The only challenge that comes with the RCT type of evidence is time. It takes a lot of time to follow up with the menopause research participants to obtain data from them. Others may fail to follow the procedure or never appear for continued care.
Search Strategy
When researching the correlation between women’s maternal and its effect on health after that, the following list of terms was used; ” Geriatric pregnancy,” “health,” “maternal age transition,” and “eligible population.” We used the Chamberlain University Library to obtain the database needed for the research since most of the articles and journals there are peer-reviewed. As part of the refinement decision, the format is purely based on the America Psychological Association criteria, filtered from 2015 onwards. Sorting was done so that only American authors’ written materials were displayed on the search list. These three were the only limits of this research exercise.
During the maternal age transition, a woman’s ovaries stop producing the chemicals estrogen and progesterone, and her monthly periods also stop. About 6,000 women enter menopause daily in the U.S. For many women, hormonal shifts occur all through after maternal age. The years preceding geriatric pregnancy are linked with psychological and physical characteristics, including irregular menstrual periods, cramps, mood swings, sleep disturbances, and cognitive difficulties. Several factors, including heredity, smoking, and chemotherapy, can increase a woman’s chance of entering maternal age before age 40. These include diseases and disorders that impair ovarian function, like main ovarian dysfunction and surgical removal of the ovaries. In some instances, the fall in hormonal levels may lead to the thickening of the bones, thereby increasing the risk of osteoporosis and high blood pressure. Seemingly, from this research, the major contributor to health problems after maternal age is barely its stage but the lifestyle associated with the participant.
One of the primary articles is written by Rozenberg et al. (2020) and strongly supports the claim that maternal aging contributes to “future fractures.” Therefore, he suggests Menopausal Hormone Therapy (MHT) as a reasonable solution “for the maintenance of skeletal health.” Despite the controversy over its side effect, it provided guidance based on the MHT, which has sparked a debate over recent years. He is careful when he says it should be offered on a benefit-risk evaluation. On the contrary, lifestyle diseases with less visible symptoms before maternal age takes advantage of the hormonal drop and swells to cause health problems. After maternal age, a woman’s estrogen levels decrease, causing her to lose bone mass more rapidly than previously, putting her at risk for osteoporosis. Osteoporosis is a disease that causes bones to be brittle, fragile, and prone to fracture. In the years preceding menopause, women with intense cramps and night sweats are more likely to experience bone loss compared to women who do not experience serious symptoms.
A recent report by the U.S. Department of Health and Human Services says maternal age may raise the risk of health problems while aging (OASH, 2022). The need to produce empirical data to back up clinical nursing practice is expanding. This is especially crucial in critical care, where the application of established procedures is subject to change when new therapies and interventions become available, and long-held norms may need to be questioned. It implies maternal age can contribute but not necessarily correlate with health problems afterward.
Conclusion
Women who experience health issues before their maternal age should have some form of therapy recommended until they turn 50 years. Only those with valid health reasons for not using hormone therapy are excluded. It is also prudent to have regular checkups. Nevertheless, maternal aging does not instigate any serious health problems. As knowledge and technology continue to unfold new information regarding this subject, we remain optimistic that a viable solution will be found. Possibly a remedy to cater for osteoporosis, the most common physical illness tied to maternal age in women. Research comparing treatments and interventions is essential to provide the best care possible. This can only be accomplished if nurses actively participate in the generation of evidence and resolve pressing research problems as they occur.
References
OASH: Office of Assistant Secretary of Health (2022). Menopause and your health. womenshealth.gov. Web.
Rozenberg, S., Al-Daghri, N., Aubertin-Leheudre, M., Brandi, M. L., Cano, A., Collins, P., Cooper C., Genazzani A. R, Hillard T., Kaufman J.-M., Lambrinoudaki I., Laslop A., McCloskey E., Palacios S., Prieto-Alhambra D., Reginster J.-Y., Rizzoli R., Rosano G., Trémollieres F. & Harvey, N. C. (2020). Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?Osteoporosis International, 31(12), 2271-2286. Web.
Takahashi, M., Singh, R. S., & Stone, J. (2017). A theory for the origin of human menopause. Frontiers in Genetics, 7, 222. Web.